Phase II trial of irinotecan (CPT-11) in relapsed or refractory non-Hodgkin's lymphomas
Ribrag, V, Koscielny, S, Vantelon, J M, Fermé, C, Rideller, K, Carde, P, Bourhis, J H, Munck, J N
Published in Leukemia & lymphoma (01.09.2003)
Published in Leukemia & lymphoma (01.09.2003)
Get full text
Journal Article
What is the place of clinical variables in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy?
Berhoune, M., Fabre-Guillevin, E., Banu, E., Scotte, F., Bonan, B., Medioni, J., Cojocarasu, O., Rideller, K., Ayllon, J., Levy, E.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article